Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/1996
12/19/1996WO1996041172A1 Functional surrogates of analytes of interest and methods of obtaining and using same
12/19/1996WO1996041170A1 Monospecific antibodies against a subunit of fibrinogen
12/19/1996WO1996041169A1 Functional bioassay for g-protein coupled receptor agonists and antagonists
12/19/1996WO1996041167A1 Relaxin diagnostic assays and kits, and methods and uses thereof
12/19/1996WO1996041166A2 Detection of transmembrane potentials by optical methods
12/19/1996WO1996041165A1 Synthetic oral fluid standard
12/19/1996WO1996041164A1 Buffer composition for reagents for immunoassay
12/19/1996WO1996041163A1 Test system for determining the activity of natural killer cells
12/19/1996WO1996041162A1 Systems and methods for identifying and controlling interfaces between blood components
12/19/1996WO1996041161A1 Monitoring concentration of molten bath components
12/19/1996WO1996041160A1 Manganese iii method for chemical oxygen demand analysis
12/19/1996WO1996041154A1 Optical trap for detection and quantitations of subzeptomolar quantities of analytes
12/19/1996WO1996041153A1 Biological cell sample holder for use in infrared and/or raman spectroscopy analysis
12/19/1996WO1996041152A1 A system and method for diagnosis of disease by infrared analysis of human tissues and cells
12/19/1996WO1996041146A2 Apparatus for measuring the crush recovery of an absorbent article
12/19/1996WO1996041144A2 Polyoxyhydrocarbyl marker products and methods for fluorescence assays
12/19/1996WO1996041139A1 Method and apparatus for hair color characterization and treatment
12/19/1996WO1996041020A1 Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
12/19/1996WO1996041019A1 Use of nucleic acid ligands in flow cytometry
12/19/1996WO1996041018A1 Methods, kits, and compositions for diagnosing papillomavirus infection
12/19/1996WO1996041015A2 Enhancement of alkaline phosphatase with sds in chemiluminescent substrates and enzyme inhibition assays
12/19/1996WO1996041013A1 Method for screening for receptor agonists and antagonists
12/19/1996WO1996041011A1 Oligonucleotide tags for sorting and identification
12/19/1996WO1996041004A1 Method for discovery of peptide receptor agonists
12/19/1996WO1996040997A1 Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans
12/19/1996WO1996040991A1 Enzyme linked oligonucleotide assays (elonas)
12/19/1996WO1996040988A1 Quenching reagents and assays for enzyme-mediated luminescence
12/19/1996WO1996040986A1 Calibrator for use in a soluble fibrin assay
12/19/1996WO1996040982A1 Therapeutic inhibition of phospholipase a2 in neurodegenerative disease
12/19/1996WO1996040980A1 Method and composition for detecting bacterial contamination in food products
12/19/1996WO1996040977A1 Origin of replication complex genes
12/19/1996WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines
12/19/1996WO1996040940A2 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
12/19/1996WO1996040939A2 Expression of functional vertebrate phospholipases in yeast
12/19/1996WO1996040932A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996WO1996040931A1 Neutralizing conformational epitopes of chicken anemia virus
12/19/1996WO1996040928A1 Streptococcal heat shock proteins members of the hsp70 family
12/19/1996WO1996040923A1 Macrophage derived chemokine and chemokine analogs
12/19/1996WO1996040922A1 Novel serpin derived from human hypothalamus
12/19/1996WO1996040916A1 Icam-4 materials and methods
12/19/1996WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996WO1996040909A1 Bone stimulating factor
12/19/1996WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996WO1996040896A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models
12/19/1996WO1996040888A1 A sample presentation apparatus for mass spectrometry
12/19/1996WO1996040885A2 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION
12/19/1996WO1996040884A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996WO1996040873A1 Standardized, primary osteoblast cell cultures taken from patients suffering from osteoporosis, and the use of these cell cultures in the diagnosis of osteoporosis and for testing potential osteoporosis therapeutic agents
12/19/1996WO1996040869A1 Early diagnostic test
12/19/1996WO1996040795A1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof
12/19/1996WO1996040790A1 Presentation of native antigen on beads or other solid phases
12/19/1996WO1996040787A1 Monoclonal antibody detection of proteins on sperm related to fertility
12/19/1996WO1996040785A1 Monospecific antibodies and methods using them
12/19/1996WO1996040777A2 Synthetic peptides and pharmaceutical compositions comprising them
12/19/1996WO1996040769A1 Developmentally-regulated endothelial cell locus-1
12/19/1996WO1996040763A2 Peptides for hiv-1 detection
12/19/1996WO1996040754A1 Immunogenic peptides of prostate specific antigen
12/19/1996WO1996040728A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds
12/19/1996WO1996040721A1 A cytotoxicity-based genetic selection system (toxsel)
12/19/1996WO1996040719A1 Endothelial-monocyte activating polypeptide iii
12/19/1996WO1996040716A1 High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones
12/19/1996WO1996040714A1 GLYCINE AND PHASEOLUS α-D-GALACTOSIDASES
12/19/1996WO1996040712A1 Nucleic acid mediated electron transfer
12/19/1996WO1996040703A1 High affinity nucleic acid ligands to lectins
12/19/1996WO1996040664A2 Preparation of immunogens and other conjugates of drugs
12/19/1996WO1996040663A1 Di- and tri-aminoguanidines and their use to inhibit the advanced glycosylation of proteins
12/19/1996WO1996040657A1 Inhibitors of phospholipase a¿2?
12/19/1996WO1996040642A1 Carbamazepine hydrazides useful in immunoassays
12/19/1996WO1996040502A1 Improved methods for the manufacture of magnetically responsive particles
12/19/1996WO1996040435A1 Device and method for phage-based antibiotic susceptibility testing
12/19/1996WO1996040402A1 Enhanced yield blood processing systems with angled interface control surface
12/19/1996WO1996040398A1 On line detection of a desired solute in an effluent stream using fluorescence spectroscopy
12/19/1996WO1996040295A1 Monoclonal antibody fragment to human ovarian cancers
12/19/1996WO1996040276A1 Screening assays for compounds
12/19/1996WO1996040251A1 Prevention and treatment of sepsis
12/19/1996WO1996040245A1 Improved delivery of diagnostic and therapeutic agents to a target site
12/19/1996WO1996040238A1 Vectors for the diagnosis and treatment of solid tumors including melanoma
12/19/1996WO1996040226A1 Method for screening potential anti-obesity agents and agent
12/19/1996WO1996040209A1 Method for identifying or isolating a molecule and molecules identified thereby
12/19/1996WO1996040197A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/19/1996WO1996040186A1 Relaxin-like factor and methods and uses thereof
12/19/1996WO1996040175A1 Stromal cell-based three-dimensional culture system for forming tubes, tendons, ligaments and corrective structures
12/19/1996WO1996040098A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
12/19/1996WO1996040065A1 Improved liposomal formulation
12/19/1996WO1996040040A2 Thrombin receptor homolog
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996039937A1 Microfabricated devices for diagnostic applications
12/19/1996WO1996039923A1 Dermal patch without a separate absorbent material
12/19/1996WO1996039922A1 Methods of minimizing scattering and improving tissue sampling in non-invasive testing and imaging
12/19/1996WO1996039834A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
12/19/1996WO1996021021A3 A cancer associated gene, testis-associated helicase (tah), protein expressed therefrom and uses thereof
12/19/1996DE19623814A1 Determn. of 5-hydroxy-indole, catecholamine and their analogues
12/19/1996DE19620636A1 Appts. for affinity processes allows multiple simultaneous analysis
12/19/1996DE19521388A1 Quantitative and qualitative determn. of analyte in sample
12/19/1996DE19521314A1 Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid Adhärenzgen from Helicobacter pylori and it polypeptide encoded
12/19/1996DE19516954C1 Verfahren zum ortsaufgelösten immunhistochemischen Nachweis von Steroidrezeptoren A method for spatially resolved immunohistochemical detection of steroid receptors
12/19/1996CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2786782A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2332731A1 Oligonucleotide tags for sorting and identification
12/19/1996CA2322765A1 Method and apparatus for hair color characterization and treatment
1 ... 3412 3413 3414 3415 3416 3417 3418 3419 3420 3421 3422 3423 3424 3425 3426 3427 3428 3429 3430 3431 3432 ... 3937